The Selexis SUREtechnology Platform™ improves the way cells are used in the discovery, development and manufacturing of recombinant protein drugs by providing key significant advantages over traditional approaches.
Your thoughts and questions are very important to us. Please feel free to EMAil us at info@selexis.com or call us directly, M-F 9:00 AM - 4:00 PM at +41 (0)22 308 93 60 (Geneva).